Dna Group (T.R.) Ltd (TLV:DNA)
Israel · Delayed Price · Currency is ILS · Price in ILA 112.90
+3.70 (3.39%)
Jul 31, 2025, 5:24 PM IDT
Dna Group (T.R.) Revenue
In the year 2024, Dna Group (T.R.) had annual revenue of 306.00K ILS. Dna Group (T.R.) had revenue of 153.00K in the half year ending December 31, 2024, a decrease of -72.68%.
Revenue
306.00K
Revenue Growth
n/a
P/S Ratio
450.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
137.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 306.00K | - | - |
| Dec 31, 2023 | 306.00K | -254.00K | -45.36% |
| Dec 31, 2022 | 560.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 235.09M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |